Novavax stock doubles after Sanofi deal marks 'new chapter' for company

  • 📰 YahooFinanceCA
  • ⏱ Reading Time:
  • 47 sec. here
  • 6 min. at publisher
  • 📊 Quality Score:
  • News: 36%
  • Publisher: 63%

John Jacobs 뉴스

Sanofi,Biotech Company,Novavax

Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.

The deal gave Novavax a much-needed cash boost as the company had flagged after a pandemic-era surge.

When asked if Sanofi had previously approached Novavax for partnership, CEO Jacobs said he couldn't comment. Novavax beat on earnings per share, at $1.08 versus consensus estimates of $1.05, but it missed on revenues, reporting $98.3 million compared to Wall Street expectations of more than $101 million.is the senior health reporter at Yahoo Finance, covering all things pharma, insurance, care services, digital health, PBMs, and health policy and politics.

If you’re looking to get into semiconductor stocks, SMH ETF is a great option. The post Like Nvidia Stock But Prefer ETFs? This Is the Best Semiconductor ETF to Invest in Artificial Intelligence appeared first on The Motley Fool Canada.Here's how these top Canadian energy infrastructure stocks could benefit from the AI data centre boom. The post With Natural Gas in Demand, 2 TSX Stocks Are Set to Heat Up appeared first on The Motley Fool Canada.

 

귀하의 의견에 감사드립니다. 귀하의 의견은 검토 후 게시됩니다.
이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

 /  🏆 47. in KR

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Novavax CEO on Sanofi deal: 'This is a new chapter in the history of our company'Novavax stock popped Friday on news of a licensing deal and minority stake from Big Pharma player Sanofi.
출처: YahooFinanceCA - 🏆 47. / 63 더 많은 것을 읽으십시오 »